Compare Immunefi (IMU) vs Mitosis (MITO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunefi vs Mitosis — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Mitosis trades at Rp387.82 (market cap Rp69,88M, Rp65,54M 24h volume). The key difference: Mitosis is far larger — about 2.6× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Mitosis for 19 Days on average.
| IMU | MITO | |
|---|---|---|
Market Cap | Rp27,03M | Rp69,88M |
Volume (24h) | Rp39,91M | Rp65,54M |
Circulating Supply | 873,4M / 10B IMU (9%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 5 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) currently trades with a market cap of Rp27.03M and a circulating supply of 873.4 million tokens (9% of max supply). The asset shows limited market activity with a short average hold time of 5 days, indicating potential speculative trading patterns. Recent coverage appears to confuse the token with a corporate entity, requiring careful verification of crypto-specific metrics.
Outlook remains cautious due to low circulation rate and potential identity confusion. Key opportunity lies in proper crypto ecosystem positioning, while major risks include liquidity constraints and market misidentification. Investors should verify on-chain metrics and exchange listings before considering exposure.
MITO is trading at Rp385.97 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The token has a market cap of Rp70.05 million and a low circulation rate of 19%, with key support at Rp352 and resistance at Rp395. Recent news highlights a corporate acquisition of a similarly named entity, but no direct protocol updates were found for the cryptocurrency.
Overall outlook is cautious due to bearish technicals and limited fundamental developments. Key opportunities include potential recovery if support holds, but risks involve low liquidity and minimal ecosystem activity. Investors should monitor for any token-specific news or network updates to reassess positioning.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
